Feb. 14 at 10:49 PM
$KAPA I noted three things in particular from the 12/10/25 podcast interview of Doctor Bhowmick. (1) at 14:00 time stamp, NIH provided funding to the company of
$3.2 million for companion biomarker study of prostate cancer, DoD provided
$1.2 million to the company for companion biomarker study of lung cancer; (2) at 23:20, Kairos is speaking to big pharma about their various trial work; (3) at 24:20, prostate cancer phase 2 study completion in about 12 months from time of interview (1/2027 is the estimated primary completion date, and also the study completion date, shown on the trial plan - see clinicaltrials.gov), lung cancer phase 1 study completion in about 18 months from time of interview (1/2027 is the primary completion date shown on the trial plan, 1/2028 is the study completion date shown on the trial plan - see clinicaltrials.gov). That was my takeaway from the interview, you may hear it differently.
